A Novel Standard for Systematic Reporting of Neuroblastoma Surgery: The International Neuroblastoma Surgical Report Form (INSRF): A Joint Initiative by the Pediatric Oncological Cooperative Groups SIOPEN∗, COG∗∗, and GPOH∗∗∗.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
pubmed:
11
7
2020
medline:
19
2
2022
entrez:
11
7
2020
Statut:
ppublish
Résumé
To create the first structured surgical report form for NBL with international consensus, to permit standardized documentation of all NBL-related surgical procedures and their outcomes. NBL, the most common extracranial solid malignant tumor in children, covers a wide spectrum of tumors with significant differences in anatomical localization, organ or vessel involvement, and tumor biology. Complete surgical resection of the primary tumor is an important part of NBL treatment, but maybe hazardous, prone to complications and its role in high-risk disease remains debated. Various surgical guidelines exist within the protocols of the different cooperative groups, although there is no standardized operative report form to document the surgical treatment of NBL. After analyzing the treatment protocols of the SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie - German Association of Pediatric Oncology and Haematology pediatric cooperative groups, important variables were defined to completely describe surgical biopsy and resection of NBL and their outcomes. All variables were discussed within the Surgical Committees of SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie - German Association of Pediatric Oncology and Haematology. Thereafter, joint meetings were organized to obtain intercontinental consensus. The "International Neuroblastoma Surgical Report Form" provides a structured reporting tool for all NBL surgery, in every anatomical region, documenting all Image Defined Risk Factors and structures involved, with obligatory reporting of intraoperative and 30 day-postoperative complications. The International Neuroblastoma Surgical Report Form is the first universal form for the structured and uniform reporting of NBL-related surgical procedures and their outcomes, aiming to facilitate the postoperative communication, treatment planning and analysis of surgical treatment of NBL.
Sections du résumé
OBJECTIVE
To create the first structured surgical report form for NBL with international consensus, to permit standardized documentation of all NBL-related surgical procedures and their outcomes.
SUMMARY OF BACKGROUND DATA
NBL, the most common extracranial solid malignant tumor in children, covers a wide spectrum of tumors with significant differences in anatomical localization, organ or vessel involvement, and tumor biology. Complete surgical resection of the primary tumor is an important part of NBL treatment, but maybe hazardous, prone to complications and its role in high-risk disease remains debated. Various surgical guidelines exist within the protocols of the different cooperative groups, although there is no standardized operative report form to document the surgical treatment of NBL.
METHODS
After analyzing the treatment protocols of the SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie - German Association of Pediatric Oncology and Haematology pediatric cooperative groups, important variables were defined to completely describe surgical biopsy and resection of NBL and their outcomes. All variables were discussed within the Surgical Committees of SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie - German Association of Pediatric Oncology and Haematology. Thereafter, joint meetings were organized to obtain intercontinental consensus.
RESULTS
The "International Neuroblastoma Surgical Report Form" provides a structured reporting tool for all NBL surgery, in every anatomical region, documenting all Image Defined Risk Factors and structures involved, with obligatory reporting of intraoperative and 30 day-postoperative complications.
CONCLUSION
The International Neuroblastoma Surgical Report Form is the first universal form for the structured and uniform reporting of NBL-related surgical procedures and their outcomes, aiming to facilitate the postoperative communication, treatment planning and analysis of surgical treatment of NBL.
Identifiants
pubmed: 32649454
pii: 00000658-202203000-00038
doi: 10.1097/SLA.0000000000003947
doi:
Types de publication
Consensus Development Conference
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e575-e585Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest and received no funding.
Références
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69:7–34.
Spix C, Pastore G, Sankila R, et al. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42:2081–2091.
Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362:2202–2211.
Brisse HJ, Blanc T, Schleiermacher G, et al. Radiogenomics of neuroblastomas: relationships between imaging phenotypes, tumor genomic profile and survival. PLoS One 2017; 12:e0185190.
Park JR, Bagatell R, Cohn SL, et al. Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol 2017; 35:2580–2587.
Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report. J Clin Oncol 2009; 27:289–297.
Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG task force report. J Clin Oncol 2009; 27:298–303.
Brisse HJ, McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011; 261:243–257.
Mullassery D, Farrelly P, Losty PD. Does aggressive surgical resection improve survival in advanced stage 3 and 4 neuroblastoma? A systematic review and meta-analysis. Pediatr Hematol Oncol 2014; 31:703–716.
La Quaglia MP, Kushner BH, Heller G, et al. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg 1994; 29:1162–1166.
Newman EA, Abdessalam S, Aldrink JH, et al. Update on neuroblastoma. J Pediatr Surg 2019; 54:383–389.
Muhling J, Eberherr C, Muller Hocker J, et al. Vessel adherent growth represents a major challenge in the surgical resection of neuroblastoma and is associated with adverse outcome. J Pediatr Surg 2019; 54:2336–2342.
Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16:459–467.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205–213.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250:187–196.
Qureshi SS, Kembhavi S, Ramadwar M, et al. Outcome and morbidity of surgical resection of primary cervical and cervicothoracic neuroblastoma in children: a comparative analysis. Pediatr Surg Int 2014; 30:267–273.
De Bernardi B, Mosseri V, Rubie H, et al. Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer 2008; 99:1027–1033.
Fischer J, Pohl A, Volland R, et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer 2017; 17:520.
von Allmen D, Davidoff AM, London WB, et al. Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 2017; 35:208–216.
Englum BR, Rialon KL, Speicher PJ, et al. Value of surgical resection in children with high-risk neuroblastoma. Pediatr Blood Cancer 2015; 62:1529–1535.
La Quaglia MP. The role of primary tumor resection in neuroblastoma: when and how much? Pediatr Blood Cancer 2015; 62:1516–1517.
Holmes K, Poetschger U, Sarnacki S, et al. The influence of surgical excision on survival in high-risk neuroblastoma revisited after introduction of ch14.18/CHO immunotherapy in the HR-NBL1/SIOPEN trial. J Clin Oncol 2018; 36: (15_Suppl): 10521–10521.
Ladenstein R, Poetschger U, Sarnacki S, et al. The influence of surgical excision on survival in high-risk neuroblastoma revisited after introduction of ch14.18/CHO immunotherapy in the HR-NBL1/SIOPEN trial. Pediatr Blood Cancer 2018; 65:S36–S37.
Braunstein SE, London WB, Kreissman SG, et al. Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: a report from the COG A3973 study. Pediatr Blood Cancer 2019; 66:e27736.
Simon T, Häberle B, Hero B, et al. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 2013; 31:752–758.
Stenman J, Herold N, Svensson PJ, et al. Improved local control by extensive surgery in high-risk neuroblastoma may be dependent on adjuvant radiotherapy. J Clin Oncol 2017; 35:1965–1966.
Holmes K, Sarnacki S, Poetschger U, et al. Influence of surgical excision on survival of patients with high risk neuroblastoma. Report from study 1 of Siop Europe (SIOPEN). Pediatr Blood Cancer 2013; 60:S3–S31.
Stewart L, Hunter JG, Wetter A, et al. Operative reports: form and function. Arch Surg 2010; 145:865–871.
Wiebe ME, Sandhu L, Takata JL, et al. Quality of narrative operative reports in pancreatic surgery. Can J Surg 2013; 56:E121–E127.
Donahoe L, Bennett S, Temple W, et al. Completeness of dictated operative reports in breast cancer–the case for synoptic reporting. J Surg Oncol 2012; 106:79–83.
Schneider L, Shargall Y, Schieman C, et al. Design of a consensus-derived synoptic operative report for lung cancer surgery. Ann Thorac Surg 2014; 97:1163–1168.
Maniar RL, Hochman DJ, Wirtzfeld DA, et al. Documentation of quality of care data for colon cancer surgery: comparison of synoptic and dictated operative reports. Ann Surg Oncol 2014; 21:3592–3597.
Edhemovic I, Temple WJ, de Gara CJ, et al. The computer synoptic operative report–a leap forward in the science of surgery. Ann Surg Oncol 2004; 11:941–947.
Maniar RL, Sytnik P, Wirtzfeld DA, et al. Synoptic operative reports enhance documentation of best practices for rectal cancer. J Surg Oncol 2015; 112:555–560.
Park J, Pillarisetty VG, Brennan MF, et al. Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg 2010; 211:308–315.
Gur I, Gur D, Recabaren JA. The computerized synoptic operative report: a novel tool in surgical residency education. Arch Surg 2012; 147:71–74.
Irtan S, Brisse HJ, Minard-Colin V, et al. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer 2015; 62:1543–1549.
Avanzini S, Pio L, Erminio G, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer 2017; 64:e26605.
Cundy TP, Kirby CP, Kirby ML. Synoptic operative reports for quality improvement in pediatric cancer care. Pediatr Blood Cancer 2018; 65:e27238.